United Therapeutics Chairperson and CEO Martine A. Rothblatt Reports $5.13 Million Common Share Sale
United Therapeutics Chairperson and CEO Martine A. Rothblatt sold 9,500 shares of common stock on Oct. 14, 2026. She exercised 9,500 stock options at $117.76 per share, leaving 233,410 options held indirectly through a trust. Sale prices ranged from $526.07 to $546 per share. The transactions left 324,443 common shares